Complete Filing Data
Celularity Inc reported Stockholders Equity of $198.90 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Celularity Inc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income * | -$57.9M | -$196.3M | $14.2M | -$100.1M | -$208.2M | $2.5M |
| Operating Income Loss | -$38.4M | -$192.3M | -$25.6M | -$109.1M | -$151.9M | -$564.3K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$57.9M | -$196.3M | $14.2M | -$100.1M | -$212.9M | $3.2M |
| Nonoperating Income Expense | -$19.5M | -$4.0M | $39.8M | $9.0M | -$61.0M | $3.7M |
| Selling General And Administrative Expense | $58.6M | $50.6M | $66.0M | $71.3M | $31.3M | |
| Research And Development Expense | $17.4M | $30.5M | $78.4M | $88.4M | $52.7M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $54.2M | $22.8M | $18.0M | $21.3M | $14.3M | |
| Other Nonoperating Income Expenses | -$9.6M | -$6.3M | -$147.0K | -$1.7M | $4.1M | |
| Other Nonoperating Income | $331.0K | $320.0K | $365.0K | $332.0K | $370.0K | |
| Income Tax Expense Benefit | $10.0K | $13.0K | $20.0K | -$4.7M | $668.2K | |
| Amortization Of Intangible Assets | $1.8M | $2.2M | $2.2M | $2.2M | $3.4M | |
| Other Nonoperating Expense | $6.3M | $3.0M | $3.2M | $2.4M | ||
| Deferred Income Tax Liabilities Net | $9.0K | $9.0K | $10.0K | $7.0K | ||
| Comprehensive Income Net Of Tax | -$57.9M | -$196.1M | $14.2M | -$100.1M | ||
| Goodwill Impairment Loss | $112.3M | $3.6M | ||||
| Cost Of Revenue | $15.0M | $16.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$23.1M | -$24.5M | -$19.8M | -$16.1M | -$6.5M | -$22.0M | -$93.9M | -$47.9M | -$64.0M | $4.8M | $47.8M | -$62.9M | $49.9M | -$64.5M | -$81.5M | -$46.3M | -$12.1M | $6.4M | $1.1M | $634.7K | -$121.00 | -$1.1K | -$545.00 | ||
| Operating Income Loss | -$12.9M | -$15.9M | -$10.5M | -$11.5M | -$10.2M | -$7.4M | -$99.3M | -$42.5M | -$63.9M | -$5.6M | $4.2M | -$41.6M | $10.9M | -$60.6M | -$44.4M | -$4.8M | -$208.2K | -$241.6K | -$202.0K | -$115.3K | -$121.00 | -$1.1K | -$545.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$23.1M | -$24.5M | -$19.8M | -$16.1M | -$6.5M | -$22.0M | -$93.9M | -$47.9M | -$64.0M | $4.8M | $47.8M | -$62.9M | $49.9M | -$64.5M | -$81.5M | -$46.3M | -$12.1M | $6.6M | $1.4M | $803.3K | -$121.00 | -$1.1K | -$545.00 | ||
| Nonoperating Income Expense | -$10.2M | -$8.7M | -$9.3M | -$4.6M | $3.7M | -$14.6M | $5.4M | -$5.5M | -$147.0K | $10.4M | $43.7M | -$21.3M | $39.0M | -$3.9M | -$37.1M | -$41.5M | $26.5K | $6.9M | $1.6M | $918.6K | |||||
| Selling General And Administrative Expense | $9.3M | $12.6M | $14.3M | $12.7M | $15.9M | $14.0M | $10.7M | $12.8M | $13.9M | $14.9M | $15.6M | $16.5M | $21.6M | $28.9M | $7.6M | $8.3M | |||||||||
| Research And Development Expense | $4.6M | $3.4M | $3.7M | $3.9M | $3.8M | $5.8M | $5.2M | $8.6M | $17.0M | $20.4M | $25.3M | $21.7M | $23.8M | $22.9M | $17.0M | $11.2M | |||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $5.3M | $5.7M | $11.4M | $9.3M | $12.1M | $14.7M | $3.8M | $2.9M | $3.9M | $4.1M | $3.8M | $5.9M | $10.6M | $3.2M | $2.7M | $3.4M | |||||||||
| Other Nonoperating Income Expenses | -$769.0K | -$4.4M | -$1.4M | -$2.9M | -$1.8M | -$897.0K | -$862.0K | -$3.2M | -$441.0K | $1.3M | $415.0K | -$327.0K | -$109.0K | -$2.0M | -$27.0K | $504.0K | |||||||||
| Other Nonoperating Income | $62.0K | $62.0K | $76.0K | $77.0K | $67.0K | $110.0K | $23.0K | $66.0K | $116.0K | $108.0K | $41.0K | $6.0K | $55.0K | $129.0K | $140.0K | $92.0K | |||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$17.0K | $17.0K | $0.00 | $43.7K | -$43.7K | $15.0K | -$38.2K | $272.6K | $298.0K | $168.7K | |||||||||
| Amortization Of Intangible Assets | $368.0K | $375.0K | $456.0K | $546.0K | $553.0K | $546.0K | $541.0K | $553.0K | $546.0K | $541.0K | $553.0K | $546.0K | $541.0K | $783.0K | |||||||||||
| Other Nonoperating Expense | $1.5M | $1.9M | $2.4M | $1.8M | $1.6M | $1.1M | $971.0K | $1.1M | $277.0K | $0.00 | $0.00 | $0.00 | $843.0K | $817.0K | $752.0K | $706.0K | |||||||||
| Deferred Income Tax Liabilities Net | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $10.0K | $10.0K | $10.0K | $7.0K | $3.9K | ||||||||||
| Comprehensive Income Net Of Tax | -$23.1M | -$24.5M | -$19.7M | -$16.1M | -$6.5M | -$22.0M | -$93.9M | -$48.2M | -$61.4M | $5.0M | $47.8M | -$62.9M | $49.9M | ||||||||||||
| Goodwill Impairment Loss | $0.00 | $0.00 | $0.00 | $82.7M | $0.00 | $29.6M | $3.6M | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Cost Of Revenue | $3.9M | $5.2M | $3.6M | $3.9M | $2.1M | $1.6M | $3.6M | $802.0K | $2.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $198.9M | $99.4M | -$531.4M | -$327.4M | $23.9K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $28.8M | $52.1M | $69.5M | $43.5M | |||
| Cash And Cash Equivalents At Carrying Value | $227.0K | $14.0M | $37.2M | $54.3M | $24.7K | ||
| Retained Earnings Accumulated Deficit | -$841.8M | -$645.5M | -$663.7M | -$563.6M | $2.5M | -$1.1K | |
| Liabilities Current | $67.3M | $62.1M | $26.2M | $26.7M | $229.1K | $150.6K | |
| Liabilities And Stockholders Equity | $143.9M | $401.1M | $414.1M | $431.0M | $291.6M | $174.5K | |
| Liabilities | $102.9M | $202.2M | $314.7M | $412.3M | $11.0M | $150.6K | |
| Assets Current | $19.8M | $33.5M | $59.1M | $72.2M | $1.0M | $24.7K | |
| Assets | $143.9M | $401.1M | $414.1M | $431.0M | $291.6M | $174.5K | |
| Change In Fair Value Of Contingent Consideration Liability | -$104.3M | -$126.3M | -$41.1M | -$55.6M | |||
| Goodwill | $7.3M | $119.7M | $123.3M | $123.3M | $127.1M | ||
| Warrant Liability | $4.4M | $3.6M | $26.0M | $76.6M | |||
| Common Stock Value | $19.0K | $15.0K | $12.0K | $1.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $814.0K | -$18.6M | -$23.3M | -$17.4M | $26.0M | ||
| Inventory Noncurrent | $16.7M | $22.9M | $2.7M | ||||
| Inventory Net | $5.8M | $5.3M | $9.5M | ||||
| Restricted Cash Noncurrent | $9.9M | $14.8M | $14.8M | $15.2M | |||
| Property Plant And Equipment Net | $67.8M | $75.7M | $90.6M | $90.1M | |||
| Other Assets Noncurrent | $337.0K | $376.0K | $355.0K | $2.9M | |||
| Intangible Assets Net Excluding Goodwill | $11.0M | $121.0M | $123.2M | $125.4M | |||
| Accounts Payable Current | $14.1M | $5.8M | $9.3M | $5.4M | |||
| Accounts And Other Receivables Net Current | $10.0M | $4.5M | $2.7M | $1.1M | |||
| Other Liabilities Noncurrent | $294.0K | $321.0K | $335.0K | $349.0K | |||
| Change In Fair Value Of Debt | $492.0K | $1.2M | $2.5M | ||||
| Contract With Customer Liability Noncurrent | $3.2M | $2.2M | $1.9M | $7.6M | |||
| Contract With Customer Liability Current | $2.8M | $2.3M | $2.2M | $4.8M | |||
| Accrued Liabilities And Other Liabilities | $7.6M | $9.1M | $11.7M | $13.5M | |||
| Allowance For Doubtful Accounts Receivable Current | $5.8M | $1.8M | $283.0K | $272.0K | |||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -$193.0K | -$104.3M | -$126.3M | -$41.1M | -$55.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$20.1M | -$25.5M | -$5.5M | $8.8M | $17.3M | $27.8M | $31.2M | $41.0M | $30.2M | $118.5M | $155.6M | $164.2M | $150.2M | $89.9M | $96.2M | -$648.2M | -$611.9M | -$536.4M | -$491.0M | -$356.8M | $5.0M | $5.0M | $23.8K | $24.5K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.3M | $10.9M | $10.3M | $11.0M | $10.3M | $10.6M | $11.9M | $10.2M | $15.1M | $17.9M | $23.4M | $57.5M | $52.8M | $62.9M | $87.4M | $22.9M | $38.1M | $96.0M | ||||||||
| Cash And Cash Equivalents At Carrying Value | $120.0K | $863.0K | $293.0K | $738.0K | $133.0K | $467.0K | $1.9M | $273.0K | $3.1M | $8.5M | $42.6M | $38.0M | $48.0M | $72.7M | $211.00 | $28.7K | $454.5K | $716.7K | $504.9K | $917.0K | $1.0M | $1.2M | $18.9K | $9.5K | ||
| Retained Earnings Accumulated Deficit | -$967.1M | -$944.0M | -$919.5M | -$899.7M | -$886.4M | -$870.3M | -$863.8M | -$851.3M | -$757.5M | -$709.5M | -$669.9M | -$674.7M | -$722.6M | -$659.6M | -$47.4M | -$39.6M | $3.4M | $3.4M | $3.5M | $1.8M | $633.4K | |||||
| Liabilities Current | $65.3M | $69.2M | $58.7M | $53.7M | $76.2M | $67.9M | $66.0M | $84.6M | $65.0M | $66.5M | $69.2M | $32.9M | $26.0M | $29.2M | $7.3M | $5.2M | $141.3K | $152.6K | $128.7K | $106.8K | $172.9K | |||||
| Liabilities And Stockholders Equity | $114.2M | $120.3M | $128.9M | $132.7M | $128.8M | $135.5M | $143.8M | $157.2M | $246.4M | $362.4M | $437.1M | $429.3M | $434.2M | $448.3M | $128.4M | $291.9M | $292.4M | $292.4M | $292.6M | $290.8M | $289.7M | |||||
| Liabilities | $134.3M | $145.8M | $134.4M | $123.8M | $111.6M | $107.7M | $112.6M | $126.9M | $127.9M | $206.8M | $272.9M | $279.2M | $344.3M | $352.1M | $47.5M | $39.8M | $11.0M | $11.0M | $11.0M | $11.0M | $11.0M | |||||
| Assets Current | $10.6M | $17.3M | $22.1M | $20.6M | $14.5M | $17.7M | $22.9M | $16.5M | $18.0M | $25.0M | $63.1M | $75.5M | $75.7M | $91.3M | $57.8K | $99.5K | $520.4K | $814.9K | $623.9K | $1.3M | $1.3M | |||||
| Assets | $114.2M | $120.3M | $128.9M | $132.7M | $128.8M | $135.5M | $143.8M | $157.2M | $246.4M | $362.4M | $437.1M | $429.3M | $434.2M | $448.3M | $128.4M | $291.9M | $292.4M | $292.4M | $292.6M | $290.8M | $289.7M | |||||
| Change In Fair Value Of Contingent Consideration Liability | $0.00 | $0.00 | $0.00 | $0.00 | -$85.4M | -$18.9M | -$33.2M | -$45.0M | $4.8M | -$48.5M | $10.0M | $20.7M | -$142.6M | |||||||||||||
| Goodwill | $7.3M | $7.3M | $7.3M | $7.3M | $7.3M | $7.3M | $7.3M | $7.3M | $90.1M | $90.1M | $123.3M | $123.3M | $123.3M | $123.3M | ||||||||||||
| Warrant Liability | $3.5M | $8.8M | $8.1M | $3.3M | $4.4M | $8.1M | $15.1M | $3.7M | $6.3M | $1.9M | $14.1M | $23.4M | $46.9M | $37.2M | ||||||||||||
| Common Stock Value | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $19.0K | $18.0K | $17.0K | $14.0K | $14.0K | $14.0K | $10.0K | $151.00 | $147.00 | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$673.0K | $1.8M | -$5.4M | $10.8M | -$31.4M | |||||||||||||||||||||
| Inventory Noncurrent | $7.0M | $7.4M | $9.4M | $12.6M | $12.8M | $14.4M | $15.6M | $24.9M | $25.3M | $24.6M | $23.9M | $2.3M | $3.2M | $3.9M | $2.7M | |||||||||||
| Inventory Net | $2.6M | $4.4M | $6.2M | $5.4M | $4.0M | $2.9M | $3.7M | $4.9M | $5.7M | $5.5M | $5.2M | $24.7M | $14.7M | $5.7M | $9.5M | |||||||||||
| Restricted Cash Noncurrent | $10.1M | $10.1M | $10.0M | $10.2M | $10.2M | $10.1M | $10.0M | $14.8M | $14.8M | $14.8M | $14.8M | $14.8M | $14.8M | $14.7M | ||||||||||||
| Property Plant And Equipment Net | $57.2M | $58.7M | $60.1M | $61.6M | $63.2M | $64.7M | $66.3M | $70.6M | $72.6M | $74.1M | $77.0M | $77.5M | $78.0M | $91.0M | ||||||||||||
| Other Assets Noncurrent | $220.0K | $242.0K | $254.0K | $270.0K | $287.0K | $305.0K | $327.0K | $354.0K | $326.0K | $352.0K | $401.0K | $784.0K | $810.0K | $354.0K | ||||||||||||
| Intangible Assets Net Excluding Goodwill | $8.1M | $8.5M | $8.9M | $9.2M | $9.6M | $10.0M | $10.5M | $11.6M | $12.1M | $120.5M | $121.5M | $122.1M | $122.6M | $123.7M | ||||||||||||
| Accounts Payable Current | $24.6M | $24.4M | $23.3M | $23.3M | $15.4M | $13.7M | $13.0M | $12.9M | $12.4M | $8.8M | $9.2M | $10.2M | $10.4M | $7.0M | ||||||||||||
| Accounts And Other Receivables Net Current | $6.7M | $11.2M | $15.0M | $13.6M | $8.8M | $13.5M | $13.8M | $4.1M | $2.8M | $3.1M | $4.5M | $3.9M | $3.6M | $1.8M | ||||||||||||
| Other Liabilities Noncurrent | $269.0K | $273.0K | $276.0K | $280.0K | $283.0K | $287.0K | $290.0K | $296.0K | $315.0K | $318.0K | $740.0K | $939.0K | $1.9M | $338.0K | ||||||||||||
| Change In Fair Value Of Debt | $824.0K | $1.1M | $12.0K | $708.0K | $67.0K | -$81.0K | -$2.0M | $1.1M | $1.3M | $291.0K | $0.00 | $0.00 | ||||||||||||||
| Contract With Customer Liability Noncurrent | $2.8M | $2.9M | $2.8M | $2.7M | $2.6M | $3.4M | $3.3M | $3.1M | $2.4M | $2.3M | $2.1M | $2.0M | $1.9M | $1.8M | ||||||||||||
| Contract With Customer Liability Current | $5.6M | $3.5M | $3.5M | $3.5M | $3.7M | $2.8M | $2.8M | $2.5M | $2.3M | $2.2M | $2.2M | $2.2M | $2.2M | $2.0M | ||||||||||||
| Accrued Liabilities And Other Liabilities | $29.4M | $33.4M | $25.2M | $19.8M | $14.5M | $10.4M | $8.8M | $10.2M | $9.4M | $9.6M | $18.5M | $20.5M | $13.4M | $17.1M | ||||||||||||
| Allowance For Doubtful Accounts Receivable Current | $6.1M | $6.2M | $6.2M | $6.3M | $6.1M | $6.1M | $6.0M | $2.2M | $2.1M | $2.4M | $1.3M | $275.0K | $518.0K | $151.0K | ||||||||||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -$18.9M | $4.8M | $20.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $11.6M | $15.0M | $15.9M | $40.0M | $4.4M | |
| Net Cash Provided By Used In Operating Activities | -$6.4M | -$38.7M | -$137.9M | -$110.1M | -$63.2M | -$1.1M |
| Net Cash Provided By Used In Investing Activities | $514.0K | -$4.0M | -$5.2M | -$5.9M | -$12.8M | -$286.8M |
| Net Cash Provided By Used In Financing Activities | $6.7M | $24.1M | $119.8M | $98.6M | $102.0M | $288.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$905.0K | -$5.6M | -$49.0K | -$3.1M | $5.8M | $92.2K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $12.6M | -$1.1M | -$2.6M | -$1.8M | $184.0K | |
| Increase Decrease In Inventories | -$6.3M | $865.0K | $16.9M | $6.4M | $643.0K | |
| Increase Decrease In Accounts Receivable | $4.0M | $6.8M | $3.6M | $1.9M | -$1.7M | |
| Increase Decrease In Accounts Payable | $9.2M | $8.5M | -$2.9M | $3.0M | $314.0K | |
| Employee Benefits And Share Based Compensation | $11.6M | $15.0M | $15.9M | $40.0M | $4.4M | |
| Depreciation Depletion And Amortization | $7.9M | $9.3M | $9.4M | $8.8M | $8.2M | |
| Payments To Acquire Property Plant And Equipment | $161.0K | $1.0M | $5.2M | $6.2M | $27.8M | |
| Increase Decrease In Other Operating Capital Net | -$300.0K | -$4.2M | $37.0K | -$2.6M | -$70.0K | |
| Proceeds From Stock Options Exercised | $58.0K | $304.0K | $862.0K | $638.0K | $138.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $2.0M | $2.4M | $2.6M | $2.7M | $3.0M | $3.0M | $3.6M | $3.9M | $4.0M | $4.5M | $4.5M | $2.4M | $8.9M | $28.2M | $1.0M | $1.1M | $1.4M | $828.0K | |||
| Net Cash Provided By Used In Operating Activities | -$3.0M | -$4.4M | -$15.0M | -$34.3M | -$25.1M | -$549.6K | -$676.00 | -$543.00 | -$545.00 | ||||||||||||
| Net Cash Provided By Used In Investing Activities | -$39.0K | -$3.2M | -$1.5M | -$1.5M | $137.5K | ||||||||||||||||
| Net Cash Provided By Used In Financing Activities | $2.3M | $6.2M | $12.8M | $46.5M | -$4.8M | -$5.2K | $25.3K | $10.0K | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$251.0K | -$294.0K | -$1.5M | $348.0K | $780.0K | $26.8K | |||||||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $2.7M | $1.2M | $729.0K | $604.0K | -$1.3M | ||||||||||||||||
| Increase Decrease In Inventories | -$2.6M | -$3.2M | $1.8M | $5.7M | $1.2M | ||||||||||||||||
| Increase Decrease In Accounts Receivable | $1.4M | $3.9M | -$791.0K | $1.1M | -$185.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable | $17.0K | -$1.2M | $2.7M | $1.3M | $85.0K | ||||||||||||||||
| Employee Benefits And Share Based Compensation | $2.6M | $3.0M | $4.0M | $2.4M | $1.0M | ||||||||||||||||
| Depreciation Depletion And Amortization | $1.8M | $2.2M | $2.4M | $2.3M | $1.9M | ||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $39.0K | $209.0K | $1.5M | $1.5M | |||||||||||||||||
| Increase Decrease In Other Operating Capital Net | -$181.0K | -$272.0K | -$96.0K | $47.0K | |||||||||||||||||
| Proceeds From Stock Options Exercised | $300.0K | $10.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.64 | -$11.02 | $0.95 | -$1.49 | -$11.31 | -$0.03 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 0.00 | 1.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 21.9M | 17.8M | 14.0M | 67.1M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 21.9M | 17.8M | 15.0M | 67.1M | |||
| Earnings Per Share Basic | $-2.64 | $-11.02 | $1.01 | $-1.49 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 730.0M | 730.0M | 730.0M | 155.6M | |||
| Common Stock Shares Outstanding | 19.4M | 14.9M | 124.3M | 18.5M | |||
| Common Stock Shares Issued | 19.4M | 14.9M | 124.3M | 18.5M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 67.1M | 18.4M | 8.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.88 | -$1.02 | -$0.84 | -$0.73 | -$0.30 | -$1.03 | -$4.98 | -$2.72 | -$4.12 | $0.03 | $0.32 | -$0.48 | $0.40 | -$2.69 | -$3.40 | -$2.52 | $0.00 | $0.04 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 26.3M | 24.0M | 23.5M | 22.0M | 21.8M | 21.4M | 18.8M | 17.7M | 15.5M | 142.7M | 140.2M | 130.4M | 106.4M | 24.0M | 18.4M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 26.3M | 24.0M | 23.5M | 22.0M | 21.8M | 21.4M | 18.8M | 17.7M | 15.5M | 150.5M | 151.3M | 130.4M | 123.6M | 24.0M | 18.4M | |||||||||
| Earnings Per Share Basic | $-0.88 | $-1.02 | $-0.84 | $-0.73 | $-0.30 | $-1.03 | $-4.98 | $-2.72 | $-4.12 | $0.03 | $0.34 | $-0.48 | $0.47 | $-2.69 | $-2.52 | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Common Stock Shares Authorized | 730.0M | 730.0M | 730.0M | 730.0M | 730.0M | 730.0M | 730.0M | 730.0M | 110.0M | 730.0M | 730.0M | 730.0M | 730.0M | 730.0M | ||||||||||
| Common Stock Shares Outstanding | 28.2M | 24.6M | 23.9M | 22.5M | 22.0M | 21.9M | 21.8M | 193.7M | 180.8M | 165.0M | 144.5M | 142.4M | 137.7M | 123.5M | ||||||||||
| Common Stock Shares Issued | 28.2M | 24.6M | 23.9M | 22.5M | 22.0M | 21.9M | 21.8M | 193.7M | 180.8M | 165.0M | 144.5M | 142.4M | 137.7M | 123.5M | ||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 130.4M | 35.2M | 24.0M | 8.7M | 26.1M | 25.6M | 8.6M | 7.3M | 7.5M | 7.5M | 7.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$398.0K | -$6.2M | -$42.1M | -$13.5M | $58.7M | ||
| Operating Income Costs And Expenses | $92.6M | $215.1M | $43.6M | $130.4M | $166.2M | ||
| Additional Paid In Capital | $882.7M | $844.4M | $763.1M | $32.4M | $2.5M | $24.1K | |
| Stock Issued During Period Value Stock Options Exercised | $58.0K | $304.0K | $948.0K | $197.0K | $138.0K | ||
| Provision For Doubtful Accounts | $457.0K | $1.2M | $1.9M | $298.0K | $292.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $87.0K | $223.0K | $683.0K | $970.0K | $806.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $4.3M | $1.3M | -$242.0K | -$714.0K | -$7.0M | $8.9M | -$5.2M | $134.0K | -$1.7M | -$9.3M | -$43.2M | $20.9M | -$39.9M | $1.2M | $36.5M | $12.0M | -$5.3M | ||||
| Operating Income Costs And Expenses | $18.2M | $21.6M | $21.9M | $20.8M | $22.3M | $22.1M | $103.0M | $45.4M | $67.8M | $9.8M | -$399.0K | $47.5M | -$276.0K | $63.8M | $47.1M | $8.2M | |||||
| Additional Paid In Capital | $947.0M | $918.5M | $914.0M | $908.5M | $903.7M | $898.1M | $895.0M | $879.2M | $873.6M | $862.5M | $833.9M | $824.9M | $812.4M | $755.8M | $1.6M | $1.6M | $1.5M | $3.2M | $4.4M | ||
| Stock Issued During Period Value Stock Options Exercised | $108.0K | $4.0K | $300.0K | $399.0K | $313.0K | $21.0K | $209.0K | $14.0K | $37.0K | $15.0K | |||||||||||
| Provision For Doubtful Accounts | -$61.0K | $201.0K | $611.0K | $235.0K | -$59.0K | ||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $11.0K | $697.0K | $1.0M | $287.0K |
Most recent annual filing with the SEC: May 8, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.